The research introduces a novel AD multifunctional nanodrug, PX@OMCN@PEG(OP)@RVGs, which efficiently inhibits tau phosphorylation and prevents Aβ aggregation (Fig. 5D). Here, MAPT is linked to Alzheimer disease.